NK

Narasimharao Kamepalli

Active Director Director DIN 10633143
DIN 10633143 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Narasimharao Kamepalli

Data last updated:

Narasimharao Kamepalli is a Director at Ayodya Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10633143
Primary Designation Director
Industry Pharma
First Appointment 17 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 20242024Active

Board colleagues of Narasimharao Kamepalli

Directorship timeline

Open interactive timeline →
Ayodya Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Narasimharao Kamepalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narasimharao Kamepalli

Narasimharao Kamepalli currently holds 1 directorship: Ayodya Pharmaceuticals Private Limited (Director, since 17 May 2024).

Narasimharao Kamepalli was first appointed on 17 May 2024 as Director at Ayodya Pharmaceuticals Private Limited.

The current boards of Narasimharao Kamepalli's companies include Akulabrahmaiah (Ayodya Pharmaceuticals Private Limited), Anantha Raghavaiah (Ayodya Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available